首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1481220篇
  免费   122978篇
  国内免费   6703篇
耳鼻咽喉   18740篇
儿科学   47699篇
妇产科学   39626篇
基础医学   203235篇
口腔科学   43188篇
临床医学   131397篇
内科学   310124篇
皮肤病学   35464篇
神经病学   122609篇
特种医学   60058篇
外国民族医学   294篇
外科学   228196篇
综合类   32693篇
现状与发展   3篇
一般理论   465篇
预防医学   122118篇
眼科学   30775篇
药学   102527篇
  5篇
中国医学   2831篇
肿瘤学   78854篇
  2019年   12069篇
  2018年   17587篇
  2017年   13744篇
  2016年   15734篇
  2015年   17747篇
  2014年   24690篇
  2013年   35747篇
  2012年   45656篇
  2011年   48732篇
  2010年   29306篇
  2009年   28314篇
  2008年   43930篇
  2007年   46887篇
  2006年   47370篇
  2005年   46255篇
  2004年   44008篇
  2003年   42459篇
  2002年   38762篇
  2001年   69824篇
  2000年   71725篇
  1999年   60008篇
  1998年   18002篇
  1997年   16091篇
  1996年   17040篇
  1995年   17092篇
  1994年   15919篇
  1993年   14849篇
  1992年   49128篇
  1991年   47773篇
  1990年   45803篇
  1989年   43634篇
  1988年   40398篇
  1987年   39576篇
  1986年   37336篇
  1985年   36027篇
  1984年   27389篇
  1983年   22934篇
  1982年   14308篇
  1981年   12865篇
  1980年   12129篇
  1979年   24321篇
  1978年   17550篇
  1977年   14782篇
  1976年   13514篇
  1975年   14180篇
  1974年   16525篇
  1973年   15855篇
  1972年   14569篇
  1971年   13393篇
  1970年   12277篇
排序方式: 共有10000条查询结果,搜索用时 359 毫秒
31.
32.

Objective

Comparative survival between neoadjuvant chemotherapy and adjuvant chemotherapy for patients with cT2-4N0-1M0 non–small cell lung cancer has not been extensively studied.

Methods

Patients with cT2-4N0-1M0 non–small cell lung cancer who received platinum-based chemotherapy were retrospectively identified. Exclusion criteria included stage IV disease, induction radiotherapy, and targeted therapy. The primary end point was disease-free survival. Secondary end points were overall survival, chemotherapy tolerance, and ability of Response Evaluation Criteria In Solid Tumors response to predict survival. Survival was estimated using the Kaplan–Meier method, compared using the log-rank test and Cox proportional hazards models, and stratified using matched pairs after propensity score matching.

Results

In total, 330 patients met the inclusion criteria (n = 92/group after propensity-score matching; median follow-up, 42 months). Five-year disease-free survival was 49% (95% confidence interval, 39-61) for neoadjuvant chemotherapy versus 48% (95% confidence interval, 38-61) for adjuvant chemotherapy (P = .70). On multivariable analysis, disease-free survival was not associated with neoadjuvant chemotherapy or adjuvant chemotherapy (hazard ratio, 1.1; 95% confidence interval, 0.64-1.90; P = .737), nor was overall survival (hazard ratio, 1.21; 95% confidence interval, 0.63-2.30; P = .572). The neoadjuvant chemotherapy group was more likely to receive full doses and cycles of chemotherapy (P = .014/0.005) and had fewer grade 3 or greater toxicities (P = .001). Response Evaluation Criteria In Solid Tumors response to neoadjuvant chemotherapy was associated with disease-free survival (P = .035); 15% of patients receiving neoadjuvant chemotherapy (14/92) had a major pathologic response.

Conclusions

Timing of chemotherapy, before or after surgery, is not associated with an improvement in overall or disease-free survival among patients with cT2-4N0-1M0 non–small cell lung cancer who undergo complete surgical resection.  相似文献   
33.
34.
35.
Metabolism describes the series of chemical reactions that are concerned with the provision of energy to biological systems. They may be divided into reactions involved in energy yield (catabolism: demand exceeds supply), and energy storage (anabolism: supply exceeds demand). Regulation of these pathways is critical for homeostasis, and derangements in metabolism are seen in a wide variety of pathological processes. Understanding metabolism is key to the treatment of many diseases, notably diabetes, as well as underpinning clinical nutritional support.  相似文献   
36.
Depigmented lesions may occur as postinflammatory sequelae of subacute cutaneous lupus erythematosus (SCLE), leading to great psychosocial impact. A 53‐year‐old male patient presented with post‐SCLE depigmented facial lesions after five years of disease stability. We proposed surgical treatment with melanocyte‐keratinocyte transplantation procedure (MKTP), and after five months the patient achieved 90% repigmentation, without Koebner phenomenon (KP). In theory, KP is a possible complication of MKTP procedure since the preparation of the receptor area involves the use of dermabrasion. In an attempt to avoid it, we suggest to maintain the treatment of the underlying disease and wait for a minimum period of disease stability before the procedure.  相似文献   
37.
38.
39.
40.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号